A pilot double-blind, randomized, and placebo-controlled study of orally administered IFN-alpha-n1 (Ins) in pediatric patients with measles.

Source:http://linkedlifedata.com/resource/pubmed/id/9781802

Download in:

View as

General Info

PMID
9781802